Evidence map›Paper›PMID 35406698›Full record

ReviewCells2022

Artificial Oocyte: Development and Potential Application.

Reza K Oqani, Seongjun So, Yeonmi Lee, Jung Jae Ko, Eunju Kang

Open access · goldAbstract readReview
In one paragraph

Review in Cells, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.4field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 8 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Reza K OqaniDepartment of Biomedical Science, College of Life Science, CHA University, Seongnam 13488, Korea.
Seongjun SoDepartment of Biomedical Science, College of Life Science, CHA University, Seongnam 13488, Korea.ORCID 0000-0002-0344-2483
Yeonmi LeeDepartment of Biomedical Science, College of Life Science, CHA University, Seongnam 13488, Korea.
Jung Jae KoDepartment of Biomedical Science, College of Life Science, CHA University, Seongnam 13488, Korea.
Eunju KangDepartment of Biomedical Science, College of Life Science, CHA University, Seongnam 13488, Korea.ORCID 0000-0002-7240-7868
CHA University Bundang Medical Center · KRCHA University · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Millions of people around the world suffer from infertility, with the number of infertile couples and individuals increasing every year. Assisted reproductive technologies (ART) have been widely developed in recent years; however, some patients are unable to benefit from these technologies due to their lack of functional germ cells. Therefore, the development of alternative methods seems necessary. One of these methods is to create artificial oocytes. Oocytes can be generated in vitro from the ovary, fetal gonad, germline stem cells (GSCs), ovarian stem cells, or pluripotent stem cells (PSCs). This approach has raised new hopes in both basic research and medical applications. In this article, we looked at the principle of oocyte development, the landmark studies that enhanced our understanding of the cellular and molecular mechanisms that govern oogenesis in vivo, as well as the mechanisms underlying in vitro generation of functional oocytes from different sources of mouse and human stem cells. In addition, we introduced next-generation ART using somatic cells with artificial oocytes. Finally, we provided an overview of the reproductive application of in vitro oogenesis and its use in human fertility.

Indexed as

InfertilityPluripotent Stem CellsFemaleGerm CellsHumansOocytesOogenesisOvaryartificial oocyteassisted reproductive technologieshaploidization of somatic chromosomesoogenesisstem cells

Identifiers

PMID35406698
PMCPMC8998074
OpenAlexW4221132509

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.